naproxen has been researched along with diethylstilbestrol in 6 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (diethylstilbestrol) | Trials (diethylstilbestrol) | Recent Studies (post-2010) (diethylstilbestrol) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 8,585 | 322 | 491 |
| Protein | Taxonomy | naproxen (IC50) | diethylstilbestrol (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 12.5893 | |
| Estrogen receptor | Homo sapiens (human) | 0.1312 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.67 | |
| Adenosine receptor A3 | Homo sapiens (human) | 2.208 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.963 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.208 | |
| Substance-K receptor | Homo sapiens (human) | 9.553 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 7.763 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 5.6 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.67 | |
| Thromboxane-A synthase | Homo sapiens (human) | 4.359 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 4.79 | |
| Adenosine receptor A2a | Homo sapiens (human) | 9.013 | |
| Adenosine receptor A1 | Homo sapiens (human) | 2.856 | |
| Mu-type opioid receptor | Homo sapiens (human) | 5.778 | |
| D(3) dopamine receptor | Homo sapiens (human) | 8.796 | |
| Delta-type opioid receptor | Homo sapiens (human) | 2.718 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 4.563 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.14 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.208 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.071 | |
| Aldehyde oxidase | Homo sapiens (human) | 0.46 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.1588 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Duffy, EM; Jorgensen, WL | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Konrádsdóttir, F; Loftsson, T; Sigfússon, SD | 1 |
1 review(s) available for naproxen and diethylstilbestrol
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
5 other study(ies) available for naproxen and diethylstilbestrol
| Article | Year |
|---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Fish skin as a model membrane: structure and characteristics.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Algorithms; Animals; Benzocaine; beta-Cyclodextrins; Catfishes; Diethylstilbestrol; Diffusion; Hydrocortisone; In Vitro Techniques; Kinetics; Lidocaine; Membranes; Models, Biological; Naproxen; Nitrates; Permeability; Picrates; Skin; Skin Absorption | 2009 |